
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research
Mingyo Kim, Yong‐Ho Choe, Sang‐Il Lee
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Mingyo Kim, Yong‐Ho Choe, Sang‐Il Lee
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Showing 20 citing articles:
Natural medicines of targeted rheumatoid arthritis and its action mechanism
Xueling Liu, Zhiguo Wang, Hua Qian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 65
Xueling Liu, Zhiguo Wang, Hua Qian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 65
Cytokines, Vascular Endothelial Growth Factors, and PlGF in Autoimmunity: Insights From Rheumatoid Arthritis to Multiple Sclerosis
Young eun Lee, Seung‐Hyo Lee, Wan‐Uk Kim
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
Young eun Lee, Seung‐Hyo Lee, Wan‐Uk Kim
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 12
Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis
In‐Woon Baek, Jung-Woo Rhim, Kyungsu Park, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
In‐Woon Baek, Jung-Woo Rhim, Kyungsu Park, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Composing On-Program Triggers and On-Demand Stimuli into Biosensor Drug Carriers in Drug Delivery Systems for Programmable Arthritis Therapy
Yan Yik Lim, Ahmad Mujahid Ahmad Zaidi, Azizi Miskon
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1330-1330
Open Access | Times Cited: 18
Yan Yik Lim, Ahmad Mujahid Ahmad Zaidi, Azizi Miskon
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1330-1330
Open Access | Times Cited: 18
Suberosin attenuates rheumatoid arthritis by repolarizing macrophages and inhibiting synovitis via the JAK/STAT signaling pathway
Huan Liu, Qianwei Li, Yuehong Chen, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
Huan Liu, Qianwei Li, Yuehong Chen, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
The HRAS-binding C2 domain of PLCη2 suppresses tumor‐like synoviocytes and experimental arthritis in rheumatoid arthritis
Hyun Min Jeon, Hae Sook Noh, Min-Gyu Jeon, et al.
Experimental & Molecular Medicine (2025)
Open Access
Hyun Min Jeon, Hae Sook Noh, Min-Gyu Jeon, et al.
Experimental & Molecular Medicine (2025)
Open Access
Development of ROS‐Sensitive Sulfasalazine‐Loaded Ferrocene Nanoparticles and Evaluation of Their Antirheumatic Effects in a 3D Synovial Hyperplasia Model
Dong Woo Kim, C.-K. Kim, Seonjoo Lee, et al.
Small (2025)
Closed Access
Dong Woo Kim, C.-K. Kim, Seonjoo Lee, et al.
Small (2025)
Closed Access
Interleukin-18 Binding Protein (IL-18BP): A Long Journey From Discovery to Clinical Application
Soohyun Kim, Hyeon Yu, Tania Azam, et al.
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Soohyun Kim, Hyeon Yu, Tania Azam, et al.
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Different modalities to manage rheumatoid arthritis: an A to Z story
Mohamed Raslan, Sara A. Raslan, Eslam M. Shehata, et al.
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Mohamed Raslan, Sara A. Raslan, Eslam M. Shehata, et al.
Future Science OA (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022
Daiana Stolz, Maria Gabriella Matera, Paola Rogliani, et al.
Breathe (2023) Vol. 19, Iss. 2, pp. 220267-220267
Open Access | Times Cited: 6
Daiana Stolz, Maria Gabriella Matera, Paola Rogliani, et al.
Breathe (2023) Vol. 19, Iss. 2, pp. 220267-220267
Open Access | Times Cited: 6
Propionibacterium freudenreichii MJ2-derived extracellular vesicles inhibit RANKL-induced osteoclastogenesis and improve collagen-induced rheumatoid arthritis
Hee-Eun Woo, Jooyoung Cho, Young‐Hee Lim
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Hee-Eun Woo, Jooyoung Cho, Young‐Hee Lim
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients
Christopher Hall, Jill Pleasance, Oliver Hickman, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4394-4394
Open Access | Times Cited: 1
Christopher Hall, Jill Pleasance, Oliver Hickman, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4394-4394
Open Access | Times Cited: 1
Role of Interleukin-17 in Predicting Activity of Rheumatoid Arthritis and Systemic Lupus Erythematosus
Sara Samaan, Sara Taha, Fatma A. Mahmoud, et al.
Clinical Medicine Insights Arthritis and Musculoskeletal Disorders (2024) Vol. 17
Open Access | Times Cited: 1
Sara Samaan, Sara Taha, Fatma A. Mahmoud, et al.
Clinical Medicine Insights Arthritis and Musculoskeletal Disorders (2024) Vol. 17
Open Access | Times Cited: 1
Inhibition Ras/MEK/ERK pathway: An important mechanism of Baihu Jia Guizhi Decoction ameliorated rheumatoid arthritis
Qi Chen, Jinming Yang, Huan Chen, et al.
Journal of Ethnopharmacology (2022) Vol. 304, pp. 116072-116072
Closed Access | Times Cited: 6
Qi Chen, Jinming Yang, Huan Chen, et al.
Journal of Ethnopharmacology (2022) Vol. 304, pp. 116072-116072
Closed Access | Times Cited: 6
Unlocking new dimensions in rheumatoid arthritis therapy: Harnessing the power of lipid based vesicles beyond traditional therapies
Richa Bahuguna, Rajendra Awasthi
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105106-105106
Closed Access | Times Cited: 3
Richa Bahuguna, Rajendra Awasthi
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105106-105106
Closed Access | Times Cited: 3
Naturopathic Interventions for Reduction of Perceived Pain in Patients Suffering from Arthritis: A Systematic Review and Meta-Analysis
Himel Mondal, Satyalakshmi Komarraju, D Sathyanath, et al.
Cureus (2024)
Open Access
Himel Mondal, Satyalakshmi Komarraju, D Sathyanath, et al.
Cureus (2024)
Open Access
Anti-rheumatic property and physiological safety of KMU-11342 in in vitro and in vivo models
Hye Suk Baek, Victor Sukbong Hong, Hyun-Su Kang, et al.
Inflammation Research (2024) Vol. 73, Iss. 8, pp. 1371-1391
Open Access
Hye Suk Baek, Victor Sukbong Hong, Hyun-Su Kang, et al.
Inflammation Research (2024) Vol. 73, Iss. 8, pp. 1371-1391
Open Access
Unlocking the Future: New Biologic Therapies for Rheumatoid Arthritis
Sarika J Patil, Vandana M Thorat, Akshada Amit Koparde, et al.
Cureus (2024)
Open Access
Sarika J Patil, Vandana M Thorat, Akshada Amit Koparde, et al.
Cureus (2024)
Open Access
Sea Hare Hydrolysate Reduces PD ‐L1 Levels in Cancer Cells and Mitigates Rheumatoid Arthritis Ina Collagen‐Induced Arthritis Mouse Model
Ji Hyeon Ryu, Min Seok Song, Marie Merci Nyiramana, et al.
Food Science & Nutrition (2024) Vol. 13, Iss. 1
Open Access
Ji Hyeon Ryu, Min Seok Song, Marie Merci Nyiramana, et al.
Food Science & Nutrition (2024) Vol. 13, Iss. 1
Open Access
Golden Age of Immunotherapy: Challenges and Opportunities
Yeonseok Chung, Seung‐Woo Lee, Wan‐Uk Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Yeonseok Chung, Seung‐Woo Lee, Wan‐Uk Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 1